Deutsch Intern
Cancer Research

AG Hudecek

Michael Hudecek: CAR T-cell Engineering

Research Hudecek Lab

We are developing novel personalized immune-based cancer treatments that involve reprogramming of the patient’s own immune system cells which are then used to target and destroy cancer cells.


We are equipping T cells (white blood cells) with a biosensor (chimeric antigen receptor, CAR) to help them detect and eliminate cancer cells.


Publications by Prof. Dr. Michael Hudecek on the Hudecek Lab website